Live Breaking News & Updates on S Dbtx Us24343r1068

Stay updated with breaking news from S dbtx us24343r1068. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Decibel Therapeutics Reports Positive Data from Interim Analysis of Ongoing Phase 1b Clinical Trial of DB-020 in Patients Receiving Cisplatin Chemotherapy

- 87% of patients who experienced ototoxicity in their placebo-treated ear were protected from ototoxicity in their DB-020-treated ear – - Data support continued development of DB-020 as a. | June 28, 2022 ....

United States , Danny Rischin , Julie Seidel , John Lee , Laurence Reid , Ben Panizza , Chris Railey , Division Of Cancer Medicine , Exchange Commission , Stern Ir Inc , Neck Cancer Centre , Chief Development Officer , American Speech Language Hearing Association , Speech Intelligibility Index , Cancer Medicine , Medical Oncology , Peter Maccallum Cancer Centre , Queensland Head , Chief Executive Officer , Decibel Therapeutics , Private Securities Litigation Reform Act , Quarterly Report , Nc Stock Exchange , Press Release , S Dbtx Us24343r1068 ,